Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page's related topics section no longer displays the 'Bladder cancer' link and the 'MedlinePlus Genetics' entry, reducing navigational links to related content.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page now adds direct links to Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study, plus the Interventions/Treatment sections and related topics (Bladder cancer, MedlinePlus Genetics), improving access to enrollment and study information. The revision label was updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check17 days agoChange DetectedRecruitment status updated to Active, not recruiting and a Completed status was added. The update includes new timestamps and a revision identifier (v3.5.5) indicating refreshed lifecycle information for the trial page.SummaryDifference0.4%

- Check38 days agoChange DetectedThe page's revision tag updated from Revision: v3.5.3 to Revision: v3.5.4. This represents a minor version update to the entry's metadata.SummaryDifference0.0%

- Check45 days agoChange DetectedThe Chicago Ridge site ZIP code was updated from 60451 to 60415. The site's recruitment status changed to Completed and Active, not recruiting, indicating enrollment activity at that location has shifted.SummaryDifference0.5%

- Check59 days agoChange DetectedThis update reflects a change in the ClinicalTrials.gov page’s revision/version indicator from v3.5.2 to v3.5.3, without altering the study’s substantive details.SummaryDifference0.0%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.